The cyclolignan picropodophyllin attenuates intimal hyperplasia after rat carotid balloon injury by blocking insulin-like growth factor-1 receptor signaling

被引:23
|
作者
Razuvaev, Anton
Henderson, Bimma
Girnita, Leonard
Larsson, Olle
Axelson, Magnus
Hedin, Ulf
Roy, Joy
机构
[1] Karolinska Inst, Cancer Ctr Karolinska, Dept Mol Med & Surg, SE-17176 Stockholm, Sweden
[2] Karolinska Inst, Dept Surg, Capio St Gorans Hosp, S-10401 Stockholm, Sweden
关键词
D O I
10.1016/j.jvs.2007.02.066
中图分类号
R61 [外科手术学];
学科分类号
摘要
Objective: Smooth muscle cell proliferation (SMC) is a pivotal factor in the development of intimal hyperplasia after vascular injury. A number of growth factors, including insulin-like growth factor-1 (IGF-1), have been shown to be involved in SMC proliferation. We evaluated the effect of picropodophyllin (PPP), a new IGF-1 receptor inhibitor, in the prevention of SMC proliferation and development of intimal hyperplasia after vascular injury. Methods: The effects of systemic administration of PPP on intimal hyperplasia were studied in a balloon rat carotid injury model. Lesions were quantified by morphometry and SMC proliferation and apoptosis was studied by immunohistochemical staining for proliferating cell nuclear antigen (PCNA) and activated caspase 3, respectively. The effect of PPP on rat aortic SMC proliferation and apoptosis was studied in vitro by using cell counting, 3[H]-thymidine incorporation, and a flow cytometry assay for annexin V. Phosphorylation of the IGF-1 receptor, protein kinase B (Akt), and extracellular signal-regulated kinase 1/2 (ERK1/2) in vitro and in vivo were analyzed by using Western blotting. Results: PPP inhibited IGF-1-mediated SMC proliferation in vitro but no significant increase in apoptosis was detected. In rats treated with PPP, a more than a twofold reduction in carotid intima area was observed 2 weeks after balloon injury, a significant decrease in PCNA staining was demonstrated in early lesions, but activated caspase 3 was not detected. In addition, PPP attenuated phosphorylation of the IGF-1 receptor, Akt, and ERK1/2 in IGF-1-stimulated SMCs in vitro, and a reduced phosphorylation of the IGF-1 receptor and Akt was found in balloon-injured carotid arteries in rats treated with PPP. Conclusion: These results show that PPP potently blocks IGF-1-mediated phosphorylation of the IGF-1 receptor in SMCs, decreases downstream Akt and ERK1/2 activation, inhibits SMC replication, and subsequently attenuates intimal hyperplasia after balloon injury of rat carotid arteries.
引用
收藏
页码:108 / 115
页数:8
相关论文
共 50 条
  • [1] Targeting the insulin-like growth factor-1 receptor by picropodophyllin for lung cancer chemoprevention
    Zhang, Qi
    Pan, Jing
    Lubet, Ronald A.
    Wang, Yian
    You, Ming
    MOLECULAR CARCINOGENESIS, 2015, 54 : E129 - E137
  • [2] Targeting the insulin-like growth factor-1 receptor by picropodophyllin as a treatment option for glioblastoma
    Yin, Shucheng
    Girnita, Ada
    Stromberg, Thomas
    Khan, Zahidul
    Andersson, Sandra
    Zheng, Huiyuan
    Ericsson, Christer
    Axelson, Magnus
    Nister, Monica
    Larsson, Olle
    Ekstrom, Tomas J.
    Girnita, Leonard
    NEURO-ONCOLOGY, 2010, 12 (01) : 19 - 27
  • [3] Resveratrol attenuates prostate cancer growth by inhibiting insulin-like growth factor-1 receptor signaling
    Sheth, Sandeep
    Jajoo, Sarvesh
    Mukherjea, Debashree
    Sheehan, Kelly
    Rybak, Leonard P.
    Ramkumar, Vickram
    CANCER RESEARCH, 2013, 73 (08)
  • [4] The inhibition of angiogenesis and tumor growth by denbinobin is associated with the blocking of insulin-like growth factor-1 receptor signaling
    Tsai, An-Chi
    Pan, Shiow-Lin
    Lai, Chin-Yu
    Wang, Chih-Ya
    Chen, Chien-Chih
    Shen, Chien-Chang
    Teng, Che-Ming
    JOURNAL OF NUTRITIONAL BIOCHEMISTRY, 2011, 22 (07): : 625 - 633
  • [5] Picropodophyllin inhibits the growth of Ewing's sarcoma cells through the insulin-like growth factor-1 receptor/Akt signaling pathway
    Wu, Yong-Tao
    Wang, Bao-Jun
    Miao, Sheng-Wu
    Gao, Jian-Jun
    MOLECULAR MEDICINE REPORTS, 2015, 12 (05) : 7045 - 7050
  • [6] EFFECTS OF AGE AND INSULIN-LIKE GROWTH FACTOR-1 ON RAT NEUROTROPHIN RECEPTOR EXPRESSION AFTER NERVE INJURY
    Luo, T. David
    Alton, Timothy B.
    Apel, Peter J.
    Cai, Jiaozhong
    Barnwell, Jonathan C.
    Sonntag, William E.
    Smith, Thomas L.
    Li, Zhongyu
    MUSCLE & NERVE, 2016, 54 (04) : 769 - 775
  • [7] Insulin Analogs Reduce Carotid Artery Intimal Hyperplasia Potentially via Insulin-like Growth Factor-1 Mediated Reduction in Oxidant Stress
    Murthy, Subramanyam N.
    Sukhanov, Sergiy
    McGee, Jennifer
    Casey, David
    Chandra, Surabhi
    Delafontaine, Patrice
    Kadowitz, Philip J.
    McNamara, Dennis B.
    Fonseca, Vivian A.
    FASEB JOURNAL, 2009, 23
  • [8] The insulin-like growth factor-1 receptor inhibitor picropodophyllin causes tumor regression and attenuates mechanisms involved in invasion of uveal melanoma cells
    Girnita, A
    All-Ericsson, C
    Economou, MA
    Åström, K
    Axelson, M
    Seregard, S
    Larsson, O
    Girnita, L
    CLINICAL CANCER RESEARCH, 2006, 12 (04) : 1383 - 1391
  • [9] Inhibition of VEGF secretion and experimental choroidal neovascularization by picropodophyllin (PPP), an inhibitor of the insulin-like growth factor-1 receptor
    Economou, Mario A.
    Wu, Jiangmei
    Vasilcanu, Daiana
    Rosengren, Linda
    All-Ericsson, Charlotta
    van der Ploeg, Ingeborg
    Menu, Eline
    Girnita, Leonard
    Axelson, Magnus
    Larsson, Olle
    Seregard, Stefan
    Kvanta, Anders
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2008, 49 (06) : 2620 - 2626
  • [10] Insulin-like growth factor-1 signaling in cardiac aging
    Lee, Wang-Soo
    Kim, Jaetaek
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2018, 1864 (05): : 1931 - 1938